Stockreport

Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF It has a couple of fantastic products in Zepbound, which is approved for weight loss, and Mounjaro, which is essentially the same thing but is approved to treat diabetes [Read more]